Is Durysta FDA Approved? An In-Depth Look at This Glaucoma Treatment
•
3 min read
On March 4, 2020, the U.S. Food and Drug Administration (FDA) approved the first-of-its-kind biodegradable implant, Durysta (bimatoprost implant), for the treatment of open-angle glaucoma and ocular hypertension. This approval introduced a new method for delivering medication directly into the eye, offering an alternative to daily eye drops for many patients.
